Men who've had a vasectomy have the simplest TRT decision matrix. The primary downside of TRT — spermatogenic suppression — is irrelevant when fertility has been surgically terminated. What remains is a straightforward risk-benefit assessment of testosterone replacement on its merits.
What Vasectomy Eliminates From the TRT Decision
- No fertility concerns: The main reason young men hesitate about TRT — potential infertility — doesn't apply
- No HCG necessity: HCG co-therapy is primarily used for fertility preservation and testicular maintenance. Without fertility goals, the case for HCG weakens considerably
- No sperm banking costs: The $500–$1,000 insurance policy of cryopreservation is unnecessary
What Remains
The vasectomy doesn't change TRT's other considerations: hematocrit monitoring, cardiovascular health assessment, prostate screening, estradiol management, and the commitment to lifelong therapy. These require the same attention regardless of fertility status.
Testicular Atrophy
Some vasectomized men still choose to use low-dose HCG specifically to prevent testicular atrophy — the cosmetic concern rather than the fertility concern. Without HCG, testicular volume typically decreases 30–50% on TRT. Whether this matters is entirely personal preference, not medical necessity.
Post-Vasectomy TRT Considerations
- Fertility suppression is irrelevant — the vasectomy already handled that
- HCG is optional (cosmetic testicular maintenance only)
- Standard TRT monitoring (hematocrit, estradiol, PSA, lipids) still applies
- The decision reduces to: do my symptoms warrant TRT, and am I committed to monitoring?
The Bottom Line
The Simplest TRT Decision
Post-vasectomy men have the cleanest TRT risk-benefit profile: all the benefits of testosterone replacement with the largest downside (fertility suppression) already neutralized. If labs confirm hypogonadism and symptoms warrant treatment, the barrier to starting is lower than for any other demographic.